Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories
-
bluebird bio (BLUE) Announces Proposed $400 Million Public Offering of Common Stock
-
bluebird bio Announces Proposed Public Offering of Common Stock
-
bluebird bio Announces Upcoming Investor Events
-
bluebird bio (BLUE) EHA a 'Solid Win', But Zynteglo’s Launch in EU Delayed - Cowen
-
bluebird bio to Present at Investor Conferences in March
-
Cowen Starts bluebird bio (BLUE) at Outperform
-
bluebird bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
bluebird bio (BLUE) Prices 3.385M Share Common Offering at $162.50/Sh
-
bluebird bio Announces Pricing of Public Offering of Common Stock
-
bluebird bio (BLUE) to Offer $400M in Common Stock
-
bluebird bio Announces Proposed Public Offering of Common Stock
-
Pre-Open Movers 03/28: (AQMS) (RSPP) (SHPG) Higher; (EDGE) (APRI) (NVTA) Lower (more...)
-
bluebird bio to Present at Investor Conferences in March
-
bluebird bio Announces Closing of Over-Allotment Option in Public Offering
-
bluebird bio (BLUE) Prices 3.24M Share Common Offering at $185/Sh
-
bluebird bio Announces Pricing of Public Offering of Common Stock
-
bluebird bio (BLUE) Commences $600M Common Stock Offering
-
bluebird bio Announces Proposed Public Offering of Common Stock
-
bluebird bio (BLUE) ASH Study Signals Steady Pipeline Progress, Remains Top Pick - Cowen
-
bluebird bio (BLUE): Data Rich Ending To 2017 - Cowen
-
bluebird bio (BLUE) Prices 3.81M Share Offering at $105/Sh
-
bluebird bio Announces Pricing of Public Offering of Common Stock
-
bluebird bio (BLUE) Announces $350M Proposed Share Offering
-
bluebird bio Announces Proposed Public Offering of Common Stock
-
bluebird bio to Present at Two Investor Conferences in March
-
bluebird bio (BLUE) Prices 3.29M Share Stock Offering for Proceeds of ~$250M
-
bluebird bio Announces Pricing of Public Offering of Common Stock
-
bluebird bio (BLUE) to Offer $200M of Common Stock
-
bluebird bio Announces Proposed Public Offering of Common Stock
-
Streetinsider.com's Hot Lunchtime Reads 11/3: (MU) (TMH) (SUPN) (BLUE)
-
Pre-Open Stock Movers 09/08: (RPRX) (RAD) (JUNO) Higher; (GEVO) (NLST) (TSCO) (PIR) Lower (more...)
-
bluebird bio to Present at Three Upcoming Investor Conferences
-
Notable Analyst Rating Changes 12/7: (ABT) (NSC) (MCC) Upgraded; (CMG) (BLUE) (ARMH) Downgraded
-
Notable Analyst Rating Changes 11/18: (CGNX) (AAPL) (TASR) Upgraded; (SALT) (XOM) (NES) Downgraded
-
bluebird bio (BLUE) Late-Breaker ASH Abstract Provides Proof-Of-Concept - Cowen
-
Too Earlier to Write Off bluebird bio's (BLUE) LentiGlobin in Subset - Cowen
-
Notable Analyst Rating Changes 10/20: (SYF) (NGLS) (RICE) Upgraded; (ENPH) (VRX) (UBNT) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 10/5: (AAPL) (ONCE) (TWTR) (BLUE)
-
bluebird bio (BLUE) Prices 2.9M Common Share Offering at $170/Share
-
bluebird bio Announces Pricing of Public Offering of Common Stock
-
bluebird bio (BLUE) Announces $400M Common Stock Offering
-
bluebird bio Announces Proposed Public Offering of Common Stock
-
bluebird bio (BLUE) Follow-Up SCD and beta-thalassemia Data Remains 'Highly Encouraging', Cowen Says
-
bluebird bio (BLUE), Celgene (CELG) 'Divorce' is a Positive for Both, Cowen Says
-
bluebird bio (BLUE) Reports $150M Stock Offering
-
bluebird bio (BLUE) Prices 3M Common Stock Offering at $34/Share
-
bluebird bio (BLUE) Announces $100M Common Stock Offering
-
Cowen Starts Bluebird Bio (BLUE) at Outperform